(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

(Reuters) -Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial ...

The world’s most profitable hedge fund has started betting against shares in GSK (GSK), the first significant short on the FTSE 100 drugmaker’s ...

With SEC fines and Congressional reprimands over meme stocks and gamified trading in its rearview mirror, Robinhood has emerged as the biggest traditional broker trading crypto, especially meme coins.

Element Capital, which returned $6B to investors in 2024 with more to come, liquidated almost its entire $2.2B U.S. equity ...

Citadel Investment Advisory Inc. lifted its position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 6.6% in the ...

We recently published a list of 12 Best Chocolate Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Citadel CEO Ken Griffin sent a stern warning Tuesday against the negative impact from President Donald Trump’s combative ...

Citadel CEO Ken Griffin had some strong words about the harmful effects of U.S. President Donald Trump's tariffs. Read more here.

A Bloomberg analysis of the major hedge funds’ regulatory filings shows their passthrough fees have exploded in recent years.